US Patent 9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Patent 9637453 was granted and assigned to FORMA Therapeutics on May, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 15, 2016
Date of Patent
May 2, 2017
Patent Applicant
Patent Application Number
15130603
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
